Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse

NCT04758000 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.

NCT NCT04758000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04758000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
Lead sponsor
Istituto Ortopedico Rizzoli
Phase
Phase 2
Overall status
Recruiting
Start date
March 1, 2021
Completion date
July 31, 2027
Enrollment
67 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ewing sarcoma, osteosarcoma